Skip to main content

Main menu

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions

Nitrogen offset in N2 multiple washout method

Katie J. Bayfield, Eric Alton, Samantha Irving, Andrew Bush, Jane C. Davies
ERJ Open Research 2020 6: 00043-2020; DOI: 10.1183/23120541.00043-2020
Katie J. Bayfield
1Imperial College London, London, UK
2Royal Brompton and Harefield NHS Foundation Trust, London, UK
3European Cystic Fibrosis Society Clinical Trials Network, Lung Clearance Index Core Facility, London, UK
4The Children's Hospital at Westmead, Sydney, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Katie J. Bayfield
  • For correspondence: katie.bayfield@health.nsw.gov.au
Eric Alton
1Imperial College London, London, UK
2Royal Brompton and Harefield NHS Foundation Trust, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Samantha Irving
1Imperial College London, London, UK
2Royal Brompton and Harefield NHS Foundation Trust, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew Bush
1Imperial College London, London, UK
2Royal Brompton and Harefield NHS Foundation Trust, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jane C. Davies
1Imperial College London, London, UK
2Royal Brompton and Harefield NHS Foundation Trust, London, UK
3European Cystic Fibrosis Society Clinical Trials Network, Lung Clearance Index Core Facility, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Addressing concerns with use of the Exhalyzer D multiple breath washout device http://bit.ly/2ug0fAi

From the authors:

Thank you for the opportunity to respond to the correspondence by J.G. Nielsen from Innovision about our recent paper [1]. We would like to respond with a few points to address any concerns that may have arisen from his comments amongst colleagues at cystic fibrosis centres using the Exhalyzer D (Eco Medics, Dürnten, Switzerland).

It is well established that the lung clearance index (LCI) values obtained from different devices are not interchangeable; the data we presented continue to emphasise that message.

J.G. Nielson is concerned that the higher LCI value obtained with the Exhalyzer D “makes the patient appear sicker” than they are. This is only the case if one judges the value against an inappropriate reference range from a different piece of equipment. Reference ranges specific to devices and gases are needed. These are being collated at present for the Exhalyzer D by our group and have recently been published by others [2].

The use of LCI in our centre is solely as an outcome measure of disease progression or therapeutic intervention. It is also the purpose of its use across the cystic fibrosis trial networks mentioned by J.G. Nielsen. What is needed in these situations is a measure with good clinimetrics [3], which relates to other understood measures or biomarkers, which reflects clinical change, and which is repeatable and reproducible. This is not the same as a requirement for accuracy or purity of measurement, which is required by those studying fundamental physiology.

The Exhalyzer D nitrogen washout has proven itself both practical in multicentre studies and sensitive to therapeutic response in the trial setting [4]. The standardisation, certification and over-reading processes put in place by the core facilities in Europe, North America and Australia [5] make it an increasingly attractive outcome measure for both academic and industrial sponsors designing drug trials for cystic fibrosis.

Irrespective of gas type, we do need to understand any offset in order to improve the multiple breath washout (MBW) technique and MBW's use as an outcome measure. This will likely involve more complicated lung models, and comparison of devices with minimal software and hardware differences, all having had appropriate in vitro and in vivo validation.

We look forward to independent research groups performing further work to improve the technique, including investigating whether a correction for the offset present can or should be applied.

Footnotes

  • Conflict of interest: K.J. Bayfield has nothing to disclose.

  • Conflict of interest: E. Alton has nothing to disclose.

  • Conflict of interest: S. Irving has nothing to disclose.

  • Conflict of interest: A. Bush has nothing to disclose.

  • Conflict of interest: J.C. Davies reports grants from the European Cystic Fibrosis Clinical Trials Network and personal fees from pharmaceutical advisory boards during the conduct of the study.

  • Received January 28, 2020.
  • Accepted February 17, 2020.
  • Copyright ©ERS 2020
http://creativecommons.org/licenses/by-nc/4.0/

This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.

References

  1. ↵
    1. Bayfield KJ,
    2. Horsley A,
    3. Alton E, et al.
    Simultaneous sulfur hexafluoride and nitrogen multiple-breath washout (MBW) to examine inherent differences in MBW outcomes. ERJ Open Res 2019; 5: 00234-2018. doi:10.1183/23120541.00234-2018
    OpenUrlAbstract/FREE Full Text
  2. ↵
    1. Anagnostopoulou P,
    2. Latzin P,
    3. Jensen R, et al.
    Normative data for multiple breath washout outcomes in school-aged Caucasian children. Eur Respir J 2019; 55: 1901302. doi:10.1183/13993003.01302-2019
    OpenUrl
  3. ↵
    1. Kent L,
    2. Reix P,
    3. Innes JA, et al.
    Lung clearance index: evidence for use in clinical trials in cystic fibrosis. J Cyst Fibros 2014; 13: 123–138. doi:10.1016/j.jcf.2013.09.005
    OpenUrlCrossRefPubMed
  4. ↵
    1. Ratjen F,
    2. Hug C,
    3. Marigowda G, et al.
    Efficacy and safety of lumacaftor and ivacaftor in patients aged 6–11 years with cystic fibrosis homozygous for F508del-CFTR: a randomised, placebo-controlled phase 3 trial. Lancet Respir Med 2017; 5: 557–567. doi:10.1016/S2213-2600(17)30215-1
    OpenUrl
  5. ↵
    1. Saunders C,
    2. Jensen R,
    3. Robinson PD, et al.
    Integrating the multiple breath washout test into international multicentre trials. J Cyst Fibros 2019; in press [https://doi.org/10.1016/j.jcf.2019.11.006].
PreviousNext
Back to top
Vol 6 Issue 1 Table of Contents
ERJ Open Research: 6 (1)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Nitrogen offset in N2 multiple washout method
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Nitrogen offset in N2 multiple washout method
Katie J. Bayfield, Eric Alton, Samantha Irving, Andrew Bush, Jane C. Davies
ERJ Open Research Jan 2020, 6 (1) 00043-2020; DOI: 10.1183/23120541.00043-2020

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Nitrogen offset in N2 multiple washout method
Katie J. Bayfield, Eric Alton, Samantha Irving, Andrew Bush, Jane C. Davies
ERJ Open Research Jan 2020, 6 (1) 00043-2020; DOI: 10.1183/23120541.00043-2020
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Footnotes
    • References
  • Info & Metrics
  • PDF

Subjects

  • Lung structure and function
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Interpreting lung oscillometry results
  • Interpreting lung oscillometry results
  • It is time to end our love affair with SABA in asthma?
Show more Correspondence

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About ERJ Open Research

  • Editorial board
  • Journal information
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Online ISSN: 2312-0541

Copyright © 2023 by the European Respiratory Society